175 related articles for article (PubMed ID: 12705339)
1. Angiogenin and gestational trophoblastic tumors, a promising prognostic marker.
Shaarawy M; El-Mallah SY; Sheiba M
Clin Chem Lab Med; 2003 Mar; 41(3):306-10. PubMed ID: 12705339
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic significance of circulating tumor suppressor gene p53 autoantibodies in patients with gestational trophoblastic tumors.
Shaarawy M; Sheiba M
Acta Oncol; 2004; 43(1):43-8. PubMed ID: 15068319
[TBL] [Abstract][Full Text] [Related]
4. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
5. Gestational trophoblastic disease and associated factors among women experiencing first trimester pregnancy loss at a regional referral hospital in central Tanzania: a cross-sectional study.
Mdoe MB; Mwakigonja AR; Mwampagatwa I
Int Health; 2023 May; 15(3):250-257. PubMed ID: 35394041
[TBL] [Abstract][Full Text] [Related]
6. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
[TBL] [Abstract][Full Text] [Related]
7. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
8. Angiogenin and MMP-2 as potential biomarkers in the differential diagnosis of gestational trophoblastic diseases.
Weng D; Han T; Dong J; Zhang M; Mi Y; He Y; Li X; Zhu X
Medicine (Baltimore); 2022 Feb; 101(5):e28768. PubMed ID: 35119039
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
10. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
14. Is normal beta-hCG regression curve helpful in the diagnosis of persistent trophoblastic disease?
Behtash N; Ghaemmaghami F; Honar H; Riazi K; Nori A; Modares M; Mousavi A
Int J Gynecol Cancer; 2004; 14(5):980-3. PubMed ID: 15361212
[TBL] [Abstract][Full Text] [Related]
15. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
[TBL] [Abstract][Full Text] [Related]
16. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
[TBL] [Abstract][Full Text] [Related]
17. [Gestational trophoblastic disease].
Allias F; Bolze PA; Gaillot-Durand L; Devouassoux-Shisheboran M;
Ann Pathol; 2014 Dec; 34(6):434-47. PubMed ID: 25499859
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid trophoblastic tumor: an unusual malignancy of ovary.
Mahmood H; Faheem M; Tahir M; Arif S; Mahmood S; Irfan J
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S201-3. PubMed ID: 25518773
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
20. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]